(Illumina Inc)

	ILMN latest price $237.3700 (-2.03%) ($236.0000 - $248.5033) on Tue. Mar. 27, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.09% (three month average)
RSI	49
Latest Price	$237.3700(-2.03%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	ILMN declines -1.3% a day on average for past five trading days.
Weekly Trend	ILMN declines -1.8% a week on average for past two weeks.
Market Behavior	Broad based sell-off for large cap. Broad based sell-off for small cap.
Correlated ETFs	Broad market will support ILMN advance at 0% a week (0% probability)   IBB(65%)    IWF(58%)    IWO(58%)    QQQ(58%)    IVW(57%)
Factors Impacting ILMN price	ILMN will decline at least -1.045% in a week (0% probabilities).   VIXM(-14%)    UUP(-12%)    SHY(-6%)    TLT(-2%)    XHB(-1%)
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.045% (StdDev 2.09%)
Hourly BBV	0 ()
Intraday Trend	-2.7%

Resistance Level	$242.85
5 Day Moving Average	$240.59(-1.34%)
10 Day Moving Average	$245.82(-3.44%)
20 Day Moving Average	$242.85(-2.26%)
To recent high	-6.5%
To recent low	13.3%
Market Cap	$34.656b

Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through Core Illumina segment, which serves customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

getNextHourMoveProbability failed